Effect of ω-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers

A randomized, placebo-controlled, double-blind trial

Kei Hamazaki, Miho Itomura, Mingming Huan, Hiroto Nishizawa, Shigeki Sawazaki, Masatoshi Tanouchi, Shiro Watanabe, Tomohito Hamazaki, Katsutoshi Terasawa, Kazunaga Yazawa

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Objective: We previously reported that administration of fish oil rich in docosahexaenoic acid (DHA) increased the plasma ratio of epinephrine to norepinephrine (NE) at rest in young adults who were under chronic stress and that this effect was achieved mainly through depression of NE. However, not many reports have documented the effects of eicosapentaenoic acid (EPA) and DHA on blood catecholamine levels in healthy humans. Therefore, we performed another intervention study to test their effect on catecholamines with healthy subjects under no chronic stress. Methods: Twenty-one healthy young adults (15 men and 6 women) were randomly assigned to an ω-3 group (n = 9) or a control group (n = 12) in a double-blind manner. Twenty capsules of shellfish-derived lipids containing 762 mg of EPA plus DHA per day were administered to the ω-3 group for 2 mo. The controls took the same amount of placebo capsules. Fasting blood samples after a 30-min rest with a catheter in a forearm vein were obtained at the start and the end of the study for catecholamine measurements. Results: EPA but not DHA concentrations in red blood cells significantly increased in the ω-3 group compared with the control group (P < 0.001). Plasma NE concentrations were significantly decreased in the ω-3 group (from 1.49 ± 0.39 nmol/L to 1.05 ± 0.14 nmol/L) compared with the control group (from 1.12 ± 0.24 nmol/L to 1.39 ± 0.32 nmol/L) with analysis of covariance (P < 0.001). The differences remained significant (P = 0.01) even after deletion of three subjects in the ω-3 group who had the highest baseline NE values and one in the control group who had the lowest baseline NE value to nullify a significant baseline differences in NE between groups. Conclusion: This study demonstrated that EPA plus DHA supplementation lowered plasma NE concentrations in normal volunteers even at the small dose of 762 mg of EPA plus DHA per day. This effect of EPA plus DHA to lower plasma NE concentrations may be important to understand some of the effects of fish oils on diseases.

Original languageEnglish
Pages (from-to)705-710
Number of pages6
JournalNutrition
Volume21
Issue number6
DOIs
Publication statusPublished - 2005 Jun
Externally publishedYes

Fingerprint

Docosahexaenoic Acids
Catecholamines
Eicosapentaenoic Acid
Phospholipids
Norepinephrine
Healthy Volunteers
Fatty Acids
Placebos
Control Groups
Fish Oils
Capsules
Young Adult
Shellfish
Forearm
Epinephrine
Veins
Fasting
Catheters
Erythrocytes
Lipids

Keywords

  • Docosahexaenoic acid
  • Eicosapentaenoic acid
  • Epinephrine
  • Fatty acid composition
  • Fish oil
  • Intervention study
  • Norepinephrine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Surgery
  • Medicine (miscellaneous)

Cite this

Effect of ω-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers : A randomized, placebo-controlled, double-blind trial. / Hamazaki, Kei; Itomura, Miho; Huan, Mingming; Nishizawa, Hiroto; Sawazaki, Shigeki; Tanouchi, Masatoshi; Watanabe, Shiro; Hamazaki, Tomohito; Terasawa, Katsutoshi; Yazawa, Kazunaga.

In: Nutrition, Vol. 21, No. 6, 06.2005, p. 705-710.

Research output: Contribution to journalArticle

Hamazaki, K, Itomura, M, Huan, M, Nishizawa, H, Sawazaki, S, Tanouchi, M, Watanabe, S, Hamazaki, T, Terasawa, K & Yazawa, K 2005, 'Effect of ω-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: A randomized, placebo-controlled, double-blind trial', Nutrition, vol. 21, no. 6, pp. 705-710. https://doi.org/10.1016/j.nut.2004.07.020
Hamazaki, Kei ; Itomura, Miho ; Huan, Mingming ; Nishizawa, Hiroto ; Sawazaki, Shigeki ; Tanouchi, Masatoshi ; Watanabe, Shiro ; Hamazaki, Tomohito ; Terasawa, Katsutoshi ; Yazawa, Kazunaga. / Effect of ω-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers : A randomized, placebo-controlled, double-blind trial. In: Nutrition. 2005 ; Vol. 21, No. 6. pp. 705-710.
@article{b98e7b40568c467c867eb1519c7f2aca,
title = "Effect of ω-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: A randomized, placebo-controlled, double-blind trial",
abstract = "Objective: We previously reported that administration of fish oil rich in docosahexaenoic acid (DHA) increased the plasma ratio of epinephrine to norepinephrine (NE) at rest in young adults who were under chronic stress and that this effect was achieved mainly through depression of NE. However, not many reports have documented the effects of eicosapentaenoic acid (EPA) and DHA on blood catecholamine levels in healthy humans. Therefore, we performed another intervention study to test their effect on catecholamines with healthy subjects under no chronic stress. Methods: Twenty-one healthy young adults (15 men and 6 women) were randomly assigned to an ω-3 group (n = 9) or a control group (n = 12) in a double-blind manner. Twenty capsules of shellfish-derived lipids containing 762 mg of EPA plus DHA per day were administered to the ω-3 group for 2 mo. The controls took the same amount of placebo capsules. Fasting blood samples after a 30-min rest with a catheter in a forearm vein were obtained at the start and the end of the study for catecholamine measurements. Results: EPA but not DHA concentrations in red blood cells significantly increased in the ω-3 group compared with the control group (P < 0.001). Plasma NE concentrations were significantly decreased in the ω-3 group (from 1.49 ± 0.39 nmol/L to 1.05 ± 0.14 nmol/L) compared with the control group (from 1.12 ± 0.24 nmol/L to 1.39 ± 0.32 nmol/L) with analysis of covariance (P < 0.001). The differences remained significant (P = 0.01) even after deletion of three subjects in the ω-3 group who had the highest baseline NE values and one in the control group who had the lowest baseline NE value to nullify a significant baseline differences in NE between groups. Conclusion: This study demonstrated that EPA plus DHA supplementation lowered plasma NE concentrations in normal volunteers even at the small dose of 762 mg of EPA plus DHA per day. This effect of EPA plus DHA to lower plasma NE concentrations may be important to understand some of the effects of fish oils on diseases.",
keywords = "Docosahexaenoic acid, Eicosapentaenoic acid, Epinephrine, Fatty acid composition, Fish oil, Intervention study, Norepinephrine",
author = "Kei Hamazaki and Miho Itomura and Mingming Huan and Hiroto Nishizawa and Shigeki Sawazaki and Masatoshi Tanouchi and Shiro Watanabe and Tomohito Hamazaki and Katsutoshi Terasawa and Kazunaga Yazawa",
year = "2005",
month = "6",
doi = "10.1016/j.nut.2004.07.020",
language = "English",
volume = "21",
pages = "705--710",
journal = "Nutrition",
issn = "0899-9007",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Effect of ω-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers

T2 - A randomized, placebo-controlled, double-blind trial

AU - Hamazaki, Kei

AU - Itomura, Miho

AU - Huan, Mingming

AU - Nishizawa, Hiroto

AU - Sawazaki, Shigeki

AU - Tanouchi, Masatoshi

AU - Watanabe, Shiro

AU - Hamazaki, Tomohito

AU - Terasawa, Katsutoshi

AU - Yazawa, Kazunaga

PY - 2005/6

Y1 - 2005/6

N2 - Objective: We previously reported that administration of fish oil rich in docosahexaenoic acid (DHA) increased the plasma ratio of epinephrine to norepinephrine (NE) at rest in young adults who were under chronic stress and that this effect was achieved mainly through depression of NE. However, not many reports have documented the effects of eicosapentaenoic acid (EPA) and DHA on blood catecholamine levels in healthy humans. Therefore, we performed another intervention study to test their effect on catecholamines with healthy subjects under no chronic stress. Methods: Twenty-one healthy young adults (15 men and 6 women) were randomly assigned to an ω-3 group (n = 9) or a control group (n = 12) in a double-blind manner. Twenty capsules of shellfish-derived lipids containing 762 mg of EPA plus DHA per day were administered to the ω-3 group for 2 mo. The controls took the same amount of placebo capsules. Fasting blood samples after a 30-min rest with a catheter in a forearm vein were obtained at the start and the end of the study for catecholamine measurements. Results: EPA but not DHA concentrations in red blood cells significantly increased in the ω-3 group compared with the control group (P < 0.001). Plasma NE concentrations were significantly decreased in the ω-3 group (from 1.49 ± 0.39 nmol/L to 1.05 ± 0.14 nmol/L) compared with the control group (from 1.12 ± 0.24 nmol/L to 1.39 ± 0.32 nmol/L) with analysis of covariance (P < 0.001). The differences remained significant (P = 0.01) even after deletion of three subjects in the ω-3 group who had the highest baseline NE values and one in the control group who had the lowest baseline NE value to nullify a significant baseline differences in NE between groups. Conclusion: This study demonstrated that EPA plus DHA supplementation lowered plasma NE concentrations in normal volunteers even at the small dose of 762 mg of EPA plus DHA per day. This effect of EPA plus DHA to lower plasma NE concentrations may be important to understand some of the effects of fish oils on diseases.

AB - Objective: We previously reported that administration of fish oil rich in docosahexaenoic acid (DHA) increased the plasma ratio of epinephrine to norepinephrine (NE) at rest in young adults who were under chronic stress and that this effect was achieved mainly through depression of NE. However, not many reports have documented the effects of eicosapentaenoic acid (EPA) and DHA on blood catecholamine levels in healthy humans. Therefore, we performed another intervention study to test their effect on catecholamines with healthy subjects under no chronic stress. Methods: Twenty-one healthy young adults (15 men and 6 women) were randomly assigned to an ω-3 group (n = 9) or a control group (n = 12) in a double-blind manner. Twenty capsules of shellfish-derived lipids containing 762 mg of EPA plus DHA per day were administered to the ω-3 group for 2 mo. The controls took the same amount of placebo capsules. Fasting blood samples after a 30-min rest with a catheter in a forearm vein were obtained at the start and the end of the study for catecholamine measurements. Results: EPA but not DHA concentrations in red blood cells significantly increased in the ω-3 group compared with the control group (P < 0.001). Plasma NE concentrations were significantly decreased in the ω-3 group (from 1.49 ± 0.39 nmol/L to 1.05 ± 0.14 nmol/L) compared with the control group (from 1.12 ± 0.24 nmol/L to 1.39 ± 0.32 nmol/L) with analysis of covariance (P < 0.001). The differences remained significant (P = 0.01) even after deletion of three subjects in the ω-3 group who had the highest baseline NE values and one in the control group who had the lowest baseline NE value to nullify a significant baseline differences in NE between groups. Conclusion: This study demonstrated that EPA plus DHA supplementation lowered plasma NE concentrations in normal volunteers even at the small dose of 762 mg of EPA plus DHA per day. This effect of EPA plus DHA to lower plasma NE concentrations may be important to understand some of the effects of fish oils on diseases.

KW - Docosahexaenoic acid

KW - Eicosapentaenoic acid

KW - Epinephrine

KW - Fatty acid composition

KW - Fish oil

KW - Intervention study

KW - Norepinephrine

UR - http://www.scopus.com/inward/record.url?scp=21144440969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21144440969&partnerID=8YFLogxK

U2 - 10.1016/j.nut.2004.07.020

DO - 10.1016/j.nut.2004.07.020

M3 - Article

VL - 21

SP - 705

EP - 710

JO - Nutrition

JF - Nutrition

SN - 0899-9007

IS - 6

ER -